Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Members Comment on Drug Safety

Staff  |  Issue: February 2009  |  February 1, 2009

Rheumatologists in the News

Lee C. Howley Sr. Prize for Research in Arthritis

Gerard Karsenty, MD, PhD, who is Paul A. Marks, MD professor and chair of the department of genetics and development at the Columbia University College of Physicians and Surgeons, and Michel Nussenzweig, PhD, Sherman Fairchild professor at Rockefeller University, both in New York City, have been awarded the Arthritis Foundation’s 2008 Lee C. Howley Sr. Prize for Research in Arthritis.

Dr. Karsenty’s research focuses on understanding the development and function of the skeletal system. He is specifically interested in transcriptional control of osteoblast differentiation, and his work paved the way for much of the present research in this field. Dr. Nussenzweig’s research on B cell development and dendritic cell function has contributed to the understanding of the etiology of rheumatoid arthritis and other autoimmune diseases, driving development of novel therapies for these diseases.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Association of Specialty Professors Honors Past President

Dennis Boulware, MD, chief of rheumatology at Kaiser Permanente in Honolulu, received the Association of Specialty Professors’ (ASP’s) 2008 Eric G. Neilson, MD, Distinguished Professor Award. He was honored for overseeing the unified staff structure under the Alliance for Academic Internal Medicine during his term as ASP president and instituting a long-range plan for the organization. He also helped bring academic general internal medicine into the ASP.

Page: 1 2 | Single Page
Share: 

Filed under:From the College Tagged with:Drug SafetyQuality Measures

Related Articles

    What Do Your Patients Think About You?

    May 9, 2012

    Why your practice needs patient-satisfaction surveys

    New ACR/ARP Committee Members Are Ready to Work

    January 16, 2020

    Volunteering is a great way to give back and can be truly meaningful. Myriad worthwhile causes exist, so it can be hard to choose among them, but donating time to ACR and ARP committees helps promote rheumatology practice and brings awareness to rheumatic diseases. The College relies on volunteers to help achieve strategic priorities, promote…

    Psoriatic Arthritis Drugs at a Glance, 2023

    April 21, 2023

    Biosimilars have become a therapeutic turning point for many patients who are living with rheumatic illnesses. Psoriatic arthritis (PsA) is a complex, multi-faceted chronic inflammatory musculoskeletal and skin disease where the treatment has changed considerably over the past few years. Psoriatic arthritis has an impact on about 30% of people with psoriasis.1 In 2019, the…

    FDA Rheumatology Update: New Drug Approvals, Plus Expanded Drug Indications & Safety Concerns

    February 12, 2020

    Last year, the FDA was busy with new biologic and other drug approvals, new and expanded drug indications, and important safety updates relevant to rheumatology…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences